反応 #61099

ord-76e6f9b745e8434ba9b0de8020255fc2

反応条件

詳細条件
See reaction.notes.procedure_details.

後処理

  1. 1
    その他was partitioned between ethyl acetate and brine
  2. 2
    抽出the organic extract
  3. 3
    乾燥was dried over sodium sulfate
  4. 4
    濃縮concentrated in vacuo
  5. 5
    その他The resulting residue purified by chromatography over silica gel
  6. 6
    洗浄eluted first with ethyl acetate
  7. 7
    洗浄gradient eluted with dichloromethane containing from 0 to 10% methanol

実験手順

(R)-tert-butoxycarbonylamino-[4-(2-morpholin-4-yl-ethoxy)-phenyl]-acetic acid (≈2.93 mmol) was dissolved in tetrahydrofuran (60 mL) and (2S,3S)-2-amino-3-phenyl-N-(4-propionyl-thiazol-2-yl)-butyramide (500 mg, 1.58 mmol) (prepared as described in example 4) was added followed by 1-[3-(dimethylamino)propyl]-3-ethylcarbodiimide hydrochloride (600 mg, 3.12 mmol) at 0° C. The reaction mixture was allowed to slowly warm to room temperature. After stirring for 5.5 hours the reaction mixture was partitioned between ethyl acetate and brine, the organic extract was dried over sodium sulfate and concentrated in vacuo. The resulting residue purified by chromatography over silica gel eluted first with ethyl acetate and then gradient eluted with dichloromethane containing from 0 to 10% methanol. {(R)-[4-(2-Morpholin-4-yl-ethoxy)-phenyl]-[(1S,2S)-2-phenyl-1-(4-propionyl-thiazol-2-ylcarbamoyl)-propylcarbamoyl]-methyl}-carbamic acid-tert-butyl ester was obtained as a white solid (146 mg, 14%).

出典

DOI: 10.6084/m9.figshare.5104873.v1特許: US07427635B2uspto-grants-2008_09